Tiziana life sciences ltd. regains compliance with nasdaq listing minimum bid price rule

New york, april 24, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces that it has received a notification from the nasdaq stock market llc (“nasdaq”) listing qualifications department informing the company that it has regained compliance with the nasdaq listing minimum bid price requirement for continued listing on the nasdaq capital market exchange.
TLSA Ratings Summary
TLSA Quant Ranking